The critical role of immune response in lung cancer and its treatment progress

New discovery., Journal Year: 2025, Volume and Issue: unknown, P. 1 - 12

Published: Feb. 28, 2025

Lung cancer, one of the most malignant tumors globally, continues to pose a significant threat human health due its high morbidity and mortality. While traditional treatments have made strides in controlling tumor growth, they often come with severe side effects. With advancements medical technology, immunotherapy has emerged as promising approach, yet there remains lack comprehensive research summarizing these methods. This paper aims review current progress for lung cancer. Conducted methods involved searching key terms such immune response cancer PubMed database, focusing on related classification, mechanisms, therapeutic strategies over past decade. The results highlight background, types, epidemiology, treatment status, anti-tumor immunity, checkpoint inhibitors, various so offer critical insights clinicians researchers lay out valuable references promote effective management

Language: Английский

Copper-Imidazopyridines Activate P53 and Cause Apoptosis in A549 Lung Cancer Cells

Published: Jan. 1, 2024

Language: Английский